Found 0 matching trials
A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1) PHASE3 This is a Phase III, multicenter, randomized, placebo-controlled trial desi...
Show More Location
Multiple Locations
Learn More & Join Trial
Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer PHASE3 RATIONALE: Drugs used in chemotherapy, such as epirubicin, cyclophosphamide...
Show More Location
Universitaetsfrauenklinik Frankfurt
Learn More & Join Trial
Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer (EBC) PHASE2 This study is a multi-center, randomized, prospective phase II clinical tri...
Show More Location
The Fourth Hospital of Hebei Medical University
Learn More & Join Trial
DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast Cancer PHASE2 Our study is a prospective, non-inferior, randomized phase II clinical tria...
Show More Location
Multiple Locations
Learn More & Join Trial
TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature PHASE2 The purpose of this study is to compare the efficacy and safety between doc...
Show More Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer PHASE3 The purpose of this study is to compare two combinations of drugs, epirubic...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer PHASE3 The Danish Breast Cancer Cooperative Group (DBCG) wishes to clarify if recu...
Show More Location
Dept. of Oncology; Aalborg Sygehus
Learn More & Join Trial
Combination Chemotherapy in Treating Women With Resected Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
U.Z. Gasthuisberg
Learn More & Join Trial
Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy, such as epirubicin, cyclophosphamide...
Show More Location
Shikoku Cancer Center
Learn More & Join Trial
Pyrotinib Plus Neoadjuvant Chemotherapy in HR+/HER2-, HER4-High Breast Cancer PHASE2 This is a Phase II, single-center, double-blind, placebo-controlled, random...
Show More Status
Active Not Recruiting
Location
Sun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University
Learn More & Join Trial